Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

Event Details

TIBSOVO® Approval Conference Call

Jul 20, 2018 at 1:00 PM EDT

Webcast Presentation

Title
TIBSOVO® Approval Conference Call
Date / Time
Jul 20, 2018 at 1:00 PM EDT